UBS Adjusts Xponential Fitness Price Target to $4.50 From $7, Maintains Neutral Rating
UBS Adjusts Xponential Fitness Price Target to $4.50 From $7, Maintains Neutral Rating
5 stories mentioning XPOFUpdated 6d ago
Every FINWIRES story that references XPOF, newest first.
Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.
UBS Adjusts Xponential Fitness Price Target to $4.50 From $7, Maintains Neutral Rating
Xponential Fitness (XPOF) along with its current and former subsidiaries are expected to pay $3.9 million to settle violations related to New York's Franchise Sales Act, Attorney General Letitia James said on Tuesday.An investigation by the Office of the Attorney General, or OAG, found that the company misled prospective franchise owners about the timeline for opening a new location while selling them franchise licenses, according to a statement.Xponential Fitness filed disclosure documents with OAG that estimated studio opening times of three to six months, while OAG's investigation found that these fitness studios took more than 13 months to open, New York Attorney General Letitia James said.As a result, Xponential Fitness estimated timelines led to significant financial losses for some franchisees, while others were ultimately never able to open their locations, James added.Xponential Fitness did not immediately respond to' request for comment.Price: $5.84, Change: $+0.33, Percent Change: +5.99%
Xponential Fitness (XPOF) shares rose more than 8% in Wednesday trading after Northland upgraded the stock to outperform from market perform, while lowering the price target to $8 from $9.Trading volume stood at more than 1.3 million shares, compared with a daily average of about 651,000.Price: $5.21, Change: $+0.38, Percent Change: +7.87%
Xponential Fitness (XPOF) has an average rating of hold and mean price target of $7.19, according to analysts polled by FactSet.